Export controls on biological agents and toxins

Introduction

Export controls on biological agents and toxins refer to legal restrictions governing the international transfer of microorganisms, biological substances, toxins, related equipment and technical information that may create risks to public health, agriculture, national security or international peace.

Biological agents include bacteria, viruses, fungi and other microorganisms capable of affecting humans, animals or plants. Biological toxins are poisonous substances produced by living organisms or derived from biological sources.

These materials have legitimate applications in vaccine development, pharmaceutical research, disease diagnosis, agriculture and scientific investigations. However, certain biological agents and toxins may also have potential applications in biological weapons. Therefore, governments establish export-control regimes to prevent unauthorised transfers and biological-weapons proliferation while allowing peaceful scientific activities.

Legal framework governing export controls in India

1. Foreign Trade (Development and Regulation) Act, 1992

The Foreign Trade (Development and Regulation) Act provides the principal statutory framework for regulating exports from India. Section 3 empowers the Central Government to prohibit, restrict or regulate exports through official orders and notifications.

The Directorate General of Foreign Trade (DGFT) administers India's export policy through the SCOMET (Special Chemicals, Organisms, Materials, Equipment and Technologies) framework.

Certain biological agents, toxins, associated equipment and technologies fall within controlled SCOMET categories. Exporters must identify the relevant classification and obtain the required authorisation before transferring controlled materials internationally.

However, not every microorganism or biological substance is automatically subject to export licensing. Classification depends on the applicable control-list entry and technical characteristics.

2. Weapons of Mass Destruction and their Delivery Systems (Prohibition of Unlawful Activities) Act, 2005

This Act establishes an important legal framework for preventing the proliferation of weapons of mass destruction. It prohibits unlawful activities involving biological, chemical and nuclear weapons and their delivery systems.

The legislation is relevant to biological agents and toxins because it addresses activities involving prohibited weapons-related purposes and transfers.

3. Environment (Protection) Act, 1986

The Environment (Protection) Act and the Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms, Genetically Engineered Organisms or Cells, 1989 regulate specified activities involving hazardous microorganisms and genetically engineered organisms.

The regulatory structure includes the Institutional Biosafety Committee (IBSC), Review Committee on Genetic Manipulation (RCGM), Genetic Engineering Appraisal Committee (GEAC), State Biotechnology Coordination Committees and District Level Committees.

Their involvement depends on the biological material and regulated activity concerned.

4. Customs Act, 1962

The Customs Act provides the enforcement framework for controlling goods entering or leaving India. Exporters must comply with applicable declarations, restrictions and licensing requirements. Unauthorised export of prohibited or restricted biological materials may result in customs enforcement action under the relevant provisions.

International legal framework

1. Biological Weapons Convention, 1972

The Biological Weapons Convention (BWC) is the principal international treaty prohibiting biological and toxin weapons.

Article I prohibits the development, production, stockpiling, acquisition or retention of biological agents and toxins of types and quantities that have no justification for prophylactic, protective or other peaceful purposes.

Article III requires states not to transfer biological weapons or related materials to recipients and not to assist others in acquiring them for prohibited purposes.

Article IV requires states to adopt necessary national measures to prohibit and prevent activities prohibited by the Convention.

The Convention does not prohibit legitimate biological research or ordinary international trade in all biological agents. Its restrictions are directed towards prohibited weapons-related purposes and activities.

2. Australia Group

The Australia Group is an informal international arrangement designed to prevent the proliferation of chemical and biological weapons.

Its participants coordinate national export controls over specified biological agents, toxins, manufacturing equipment and related technologies. Its control lists influence national licensing systems, including India's SCOMET framework.

3. United Nations Security Council Resolution 1540 (2004)

Resolution 1540 requires states to establish effective domestic controls to prevent non-state actors from acquiring biological, chemical and nuclear weapons.

It specifically calls for appropriate controls over exports, transit, trans-shipment and related materials. It strengthens international cooperation in preventing the illicit movement of sensitive biological substances.

4. International Health Regulations, 2005

The International Health Regulations provide a framework for international cooperation in preventing and responding to public health emergencies. They are relevant to the safe management and reporting of certain biological risks, although they do not establish a general export-licensing system for biological agents.

Major legal issues concerning biological-agent exports

1. Dual-use research and national security

Many biological agents have legitimate scientific applications but may also create security risks. Export authorities must distinguish peaceful research activities from prohibited biological-weapons-related transfers.

2. Licensing and end-user verification

Exporters may be required to obtain licences and verify the identity, location and intended activities of foreign recipients. Failure to comply with applicable authorisation conditions may result in administrative or criminal consequences.

3. International cooperation

Biological materials can cross national borders through commercial shipments, academic collaborations and research partnerships. Effective control requires cooperation between customs authorities, scientific regulators and international organisations.

4. Scientific freedom and access to research materials

Overly restrictive export controls may interfere with medical research, vaccine development and international scientific collaboration. Regulatory authorities must therefore balance national security with legitimate scientific and public health interests.

5. Liability for unauthorised transfers

Companies, research institutions and individuals may face legal consequences for knowingly violating applicable export restrictions. Liability depends on the relevant legislation, the nature of the material, the person's conduct and the required legal elements.

Important judicial and international decisions

1. United States v. Roth (2011)

This case involved unlawful export-related conduct concerning sensitive military technology. Although it did not concern biological agents or toxins, it demonstrates the importance of export licensing and compliance with restrictions on controlled materials and technologies.

2. United States v. Zhen Zhou Wu (2014)

This prosecution concerned the unlawful export of sensitive technology from the United States. Its relevance is indirect because it illustrates the consequences of transferring controlled technology without the necessary authorisation.

3. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

The Supreme Court of India emphasised the importance of scientific expertise in environmental decision-making where complex scientific uncertainty exists. This principle is relevant by analogy to regulatory assessments involving biological agents and potential public health risks.

4. Vellore Citizens' Welfare Forum v. Union of India (1996)

The Supreme Court recognised the precautionary principle as part of Indian environmental law. The principle supports preventive regulatory action where biological activities may create serious environmental or public health risks.

5. United States v. Alvarez-Machain (1992)

This decision concerned international legal questions relating to the abduction of a criminal defendant and is not a direct authority on biological export controls. It should not be treated as establishing specific rules for the international transfer of biological agents.

Compliance requirements for exporters

Organisations exporting biological agents and toxins should establish a documented compliance programme covering:

Classification: Identify whether the biological material appears on applicable SCOMET or other national control lists.

Licensing: Obtain prior export authorisation wherever legally required.

End-user screening: Verify the foreign recipient and intended peaceful use.

Documentation: Maintain material descriptions, shipping records, licences and relevant declarations.

Biosafety: Comply with applicable containment, handling and transportation requirements.

Customs compliance: Make accurate export declarations and follow applicable customs procedures.

Internal audits: Review export transactions and update compliance procedures when control lists change.

Conclusion

Export controls on biological agents and toxins are essential for preventing biological-weapons proliferation and protecting public health and national security. India's Foreign Trade Act, WMD Act, Environment (Protection) Act and Customs Act provide important domestic regulatory foundations. International instruments such as the Biological Weapons Convention, Australia Group framework and UN Security Council Resolution 1540 strengthen these controls. Although direct judicial decisions specifically concerning biological-agent export restrictions remain limited, export-control and environmental jurisprudence provide relevant legal principles. An effective regulatory system must combine scientific risk assessment, licensing, end-user verification, transparent documentation and international cooperation.